Serratia marcescens as a postoperative pathogen

T. W. Williams, J. E. Sailer, J. Viroslav, V. Knight, N. Glasgow, N. Moreland

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Serratia marcescens is becoming a frequent nosocomial pathogen. Portals of entry include indwelling intravenous or intraperitoneal polyethylene catheters, indwelling bladder catheters or urologic instrumentation, and inhalation therapy equipment. Twenty-four isolates were tested for in vitro susceptibility to nine antibiotics. The majority of the strains were nonpigmented and resistent to most antimicrobial agents except gentamicin, nalidixic acid, and chloramphenicol. Four cases are reported illustrating the severity of the disease, portals of entry, and response to therapy. Empirical therapy for systemic S marcescens infection should start with gentamicin.

Original languageEnglish (US)
Pages (from-to)64-69
Number of pages6
JournalThe American Journal of Surgery
Volume122
Issue number1
DOIs
StatePublished - 1971

Fingerprint

Serratia marcescens
Gentamicins
Respiratory Therapy
Nalidixic Acid
Indwelling Catheters
Polyethylene
Chloramphenicol
Anti-Infective Agents
Urinary Bladder
Catheters
Anti-Bacterial Agents
Equipment and Supplies
Therapeutics
Infection
In Vitro Techniques

ASJC Scopus subject areas

  • Surgery

Cite this

Williams, T. W., Sailer, J. E., Viroslav, J., Knight, V., Glasgow, N., & Moreland, N. (1971). Serratia marcescens as a postoperative pathogen. The American Journal of Surgery, 122(1), 64-69. https://doi.org/10.1016/0002-9610(71)90350-3

Serratia marcescens as a postoperative pathogen. / Williams, T. W.; Sailer, J. E.; Viroslav, J.; Knight, V.; Glasgow, N.; Moreland, N.

In: The American Journal of Surgery, Vol. 122, No. 1, 1971, p. 64-69.

Research output: Contribution to journalArticle

Williams, TW, Sailer, JE, Viroslav, J, Knight, V, Glasgow, N & Moreland, N 1971, 'Serratia marcescens as a postoperative pathogen', The American Journal of Surgery, vol. 122, no. 1, pp. 64-69. https://doi.org/10.1016/0002-9610(71)90350-3
Williams, T. W. ; Sailer, J. E. ; Viroslav, J. ; Knight, V. ; Glasgow, N. ; Moreland, N. / Serratia marcescens as a postoperative pathogen. In: The American Journal of Surgery. 1971 ; Vol. 122, No. 1. pp. 64-69.
@article{8801475109374381b180280df9ba6b82,
title = "Serratia marcescens as a postoperative pathogen",
abstract = "Serratia marcescens is becoming a frequent nosocomial pathogen. Portals of entry include indwelling intravenous or intraperitoneal polyethylene catheters, indwelling bladder catheters or urologic instrumentation, and inhalation therapy equipment. Twenty-four isolates were tested for in vitro susceptibility to nine antibiotics. The majority of the strains were nonpigmented and resistent to most antimicrobial agents except gentamicin, nalidixic acid, and chloramphenicol. Four cases are reported illustrating the severity of the disease, portals of entry, and response to therapy. Empirical therapy for systemic S marcescens infection should start with gentamicin.",
author = "Williams, {T. W.} and Sailer, {J. E.} and J. Viroslav and V. Knight and N. Glasgow and N. Moreland",
year = "1971",
doi = "10.1016/0002-9610(71)90350-3",
language = "English (US)",
volume = "122",
pages = "64--69",
journal = "American Journal of Surgery",
issn = "0002-9610",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Serratia marcescens as a postoperative pathogen

AU - Williams, T. W.

AU - Sailer, J. E.

AU - Viroslav, J.

AU - Knight, V.

AU - Glasgow, N.

AU - Moreland, N.

PY - 1971

Y1 - 1971

N2 - Serratia marcescens is becoming a frequent nosocomial pathogen. Portals of entry include indwelling intravenous or intraperitoneal polyethylene catheters, indwelling bladder catheters or urologic instrumentation, and inhalation therapy equipment. Twenty-four isolates were tested for in vitro susceptibility to nine antibiotics. The majority of the strains were nonpigmented and resistent to most antimicrobial agents except gentamicin, nalidixic acid, and chloramphenicol. Four cases are reported illustrating the severity of the disease, portals of entry, and response to therapy. Empirical therapy for systemic S marcescens infection should start with gentamicin.

AB - Serratia marcescens is becoming a frequent nosocomial pathogen. Portals of entry include indwelling intravenous or intraperitoneal polyethylene catheters, indwelling bladder catheters or urologic instrumentation, and inhalation therapy equipment. Twenty-four isolates were tested for in vitro susceptibility to nine antibiotics. The majority of the strains were nonpigmented and resistent to most antimicrobial agents except gentamicin, nalidixic acid, and chloramphenicol. Four cases are reported illustrating the severity of the disease, portals of entry, and response to therapy. Empirical therapy for systemic S marcescens infection should start with gentamicin.

UR - http://www.scopus.com/inward/record.url?scp=0015097337&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0015097337&partnerID=8YFLogxK

U2 - 10.1016/0002-9610(71)90350-3

DO - 10.1016/0002-9610(71)90350-3

M3 - Article

C2 - 4326385

AN - SCOPUS:0015097337

VL - 122

SP - 64

EP - 69

JO - American Journal of Surgery

JF - American Journal of Surgery

SN - 0002-9610

IS - 1

ER -